Literature DB >> 14972472

Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.

Jennifer L Beebe-Dimmer1, David P Wood, Stephen B Gruber, Julie A Douglas, Joseph D Bonner, Caroline Mohai, Kimberly A Zuhlke, Cassandra Shepherd, Kathleen A Cooney.   

Abstract

OBJECTIVES: To describe the use of complementary and alternative medicines (CAMs) among men with a family history of prostate cancer and to evaluate the relationship between selected sociodemographic and behavioral characteristics and the use of CAMs.
METHODS: Unaffected brothers of men diagnosed with prostate cancer were asked to participate in a short computer-assisted telephone interview. The survey focused primarily on the use of different vitamins, herbal supplements, and medications, some of which are marketed for prostate health or prostate cancer prevention.
RESULTS: A total of 111 men completed the survey, representing 66% of eligible study subjects. Of the 111 men, 61 (55%) reported currently taking some form of CAM, with 30% taking a vitamin or supplement purported to have prostate-specific benefits. The prevalence of CAM use generally increased with increasing age; however, men who were younger than their affected brother at the time of the diagnosis of prostate cancer were more likely to use CAMs than were older brothers.
CONCLUSIONS: Most men with a family history of prostate cancer take vitamins and supplements, some of which are believed to prevent future cancer occurrence. The results of this study and others provide some insight into the determinants of potentially beneficial health behaviors in high-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972472     DOI: 10.1016/j.urology.2003.09.036

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

2.  Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centre.

Authors:  LeQuyen Luc; Charlotte Baumgart; Edward Weiss; Lesley Georger; Christine B Ambrosone; Gary Zirpoli; Susan E McCann
Journal:  Public Health Nutr       Date:  2014-05-27       Impact factor: 4.022

3.  Treatment- and disease-related complications of prostate cancer.

Authors:  Anne R Simoneau
Journal:  Rev Urol       Date:  2006

4.  Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer.

Authors:  Christina M Bauer; Miriam B Ishak; Emilie K Johnson; Jennifer L Beebe-Dimmer; Kathleen A Cooney
Journal:  Integr Cancer Ther       Date:  2011-08-05       Impact factor: 3.279

5.  Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.

Authors:  Koji Yoshimura; Nobufumi Ueda; Kentaro Ichioka; Yoshiyuki Matsui; Akito Terai; Yoichi Arai
Journal:  Support Care Cancer       Date:  2005-06-10       Impact factor: 3.603

6.  Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.

Authors:  Miriam B Ishak-Howard; Linda A Okoth; Kathleen A Cooney
Journal:  Urology       Date:  2014-04-16       Impact factor: 2.649

7.  Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.

Authors:  Lauren P Wallner; Aruna V Sarma; Michael M Lieber; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Monica E Gowan; Steven J Jacobsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

Review 8.  Lycopene for the prevention of prostate cancer.

Authors:  Dragan Ilic; Kristian M Forbes; Craig Hassed
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 9.  Are We Sentenced to Pharmacotherapy? Promising Role of Lycopene and Vitamin A in Benign Urologic Conditions.

Authors:  Piotr Kutwin; Piotr Falkowski; Roman Łowicki; Magdalena Borowiecka-Kutwin; Tomasz Konecki
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

10.  Use of complementary and alternative medicine before and after organ removal due to urologic cancer.

Authors:  Jens Mani; Eva Juengel; Ilhan Arslan; Georg Bartsch; Natalie Filmann; Hanns Ackermann; Karen Nelson; Axel Haferkamp; Tobias Engl; Roman A Blaheta
Journal:  Patient Prefer Adherence       Date:  2015-10-01       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.